Chesnara Plc: Fourth acquisition in two years
12 November 2026
Savara, Inc. (NASDAQ: SVRA) presents a compelling opportunity for investors in the biotech sector, with a staggering 158.66% potential upside, according to recent analyst ratings. As..
For investors keen on the healthcare sector, particularly in medical devices, Treace Medical Concepts, Inc. (NASDAQ: TMCI) presents a curious case of innovation and opportunity. Specializing..
MeiraGTx Holdings plc (MGTX), a promising player in the biotechnology sector, is capturing investor attention with a staggering potential upside of 228%. As a clinical-stage gene..
Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, is gaining investor attention in the dynamic biotechnology sector. With a promising..
Investors keeping an eye on the biotechnology sector may find REGENXBIO Inc. (NASDAQ: RGNX) a compelling opportunity, particularly given the company’s significant potential upside. With a..
Replimune Group, Inc. (NASDAQ: REPL) stands at the forefront of innovation in the biotechnology sector, with a focus on developing and commercializing oncolytic immunotherapies to combat..
Surmodics, Inc. (SRDX), a key player in the healthcare sector, specializes in performance coating technologies for intravascular medical devices and chemical and biological components for in..
AMN Healthcare Services Inc (NYSE: AMN), a prominent name in the healthcare sector, stands as a vital player in the medical care facilities industry in the..
Arcus Biosciences, Inc. (NASDAQ: RCUS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its robust development pipeline aimed at tackling various cancers...
Cel-Sci Corporation (CVM), a clinical-stage biotechnology company, has captured the attention of investors with a staggering potential upside of 3,585.87%. This potential is reflected in the..
Ginkgo Bioworks Holdings, Inc. (DNA), a pioneering entity in the biotechnology sector, is at a critical juncture with its innovative approach to cell programming and biosecurity...
For investors with an eye on the biotechnology sector, Geron Corporation (NASDAQ: GERN) presents an intriguing opportunity. With a market capitalization of approximately $925.12 million, this..
Keros Therapeutics, Inc. (NASDAQ: KROS) stands out in the biotechnology sector with its focus on developing innovative therapeutics for disorders related to dysfunctional signaling of the..
LifeMD, Inc. (NASDAQ: LFMD), a burgeoning player in the healthcare sector, operates within the rapidly expanding field of health information services. With a market capitalization of..
In the burgeoning field of medical devices, Butterfly Network, Inc. (NASDAQ: BFLY) stands out with its innovative approach to ultrasound imaging solutions. Despite the challenges faced..
Neuropace, Inc. (NPCE), a prominent player in the healthcare sector specializing in medical devices, presents a compelling case for investors with its innovative contributions to the..
STAAR Surgical Company (NASDAQ: STAA) has been a prominent name in the medical instruments and supplies industry for decades, with its innovative implantable lenses and laser-based..
Arbutus Biopharma Corporation (NASDAQ: ABUS) is making waves in the biotechnology sector with a potential upside of 55.32%, according to recent analyst ratings. As a clinical-stage..
Zenas BioPharma, Inc. (NASDAQ: ZBIO), a clinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts, is capturing the attention of investors with its innovative approach to immunology-based therapies...
Claritev Corporation (CTEV), a prominent player in the healthcare sector, operates in the specialized niche of health information services. With a market capitalization of $1.12 billion,..
